BioRestorative Therapies ...

NASDAQ: BRTX · Real-Time Price · USD
1.51
0.01 (0.65%)
At close: Aug 15, 2025, 3:50 PM
1.52
0.66%
After-hours: Aug 15, 2025, 04:00 PM EDT

BioRestorative Therapies Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-10.72M -12.1M -8.98M -6.17M -8M -6.96M -10.42M -15.94M -17.67M -19.36M -18.49M -34.55M -34.08M -33.47M -44.3M -29.66M -26.31M -19.38M
Depreciation & Amortization
203.17K 198.12K 189.06K 181.4K 175.28K 169.1K 165.74K 154.82K 143.9K 133.88K 120.55K 110.25K 100.6K 90.92K 89.11K 93.08K 96.97K 101.82K
Stock-Based Compensation
2.94M 2.79M 2.81M 4.1M 5.31M 6.43M 7.78M 9.38M 10.96M 12.62M 12.61M 12.73M 12.59M 12.41M 23.11M 20M 17.25M 14.55M
Other Working Capital
-36.99K 94.54K -95.93K 20.8K 90.11K -1.72K 539.44K 325.61K 69.63K 56.2K -94.93K -171.14K 136.82K 544.17K 1.96M 4.24M 2.79M 1.75M
Other Non-Cash Items
-2.31M -60.01K -2.28M -4.27M -3.08M -4.65M -2.96M 73.16K 93.05K 93.05K -123.54K -49.02K 278.05K 627.6K 1.27M 6.77M 6.41M 1.66M
Deferred Income Tax
n/a n/a n/a -1.57M -1.53M -1.52M -1.52M 52K 11.01K n/a n/a 16.18M 16.18M 16.18M 16.18M n/a n/a n/a
Change in Working Capital
369.42K 473.14K 28.65K 69.12K -11.72K 78.29K 515.33K 50.87K -41.55K -65.11K 14.14K 132.8K 314.14K 48.61K 324.69K 41.76K -93.46K 737.85K
Operating Cash Flow
-9.52M -8.69M -8.23M -7.66M -7.13M -6.4M -6.43M -6.23M -6.5M -6.62M -5.87M -5.44M -4.62M -4.11M -3.33M -2.76M -2.65M -2.33M
Capital Expenditures
-70.89K -106.19K -106.19K -163.78K -117.27K -111.02K -171.04K -318.6K -282.05K -390.67K -440.22K -253.3K -277.9K -140.23K -30.66K n/a n/a n/a
Cash Acquisitions
n/a n/a n/a -170.69K 267.15K 267.15K 267.15K 437.84K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-10.23M -11.21M -20.89M -35.4M -30.33M -34.34M -25.08M -11.08M -20.57M -14.51M -13.04M -9.93M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
17.31M 19.17M 21.51M 34.64M 28.57M 24.2M 20.96M 3.69M 3.26M 2.57M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 170.69K -267.15K 427.7K 3M -375.41K -9.87M -10.57M -13.24M -10.07M -140.23K -140.23K -30.66K n/a n/a n/a
Investing Cash Flow
6.97M 7.81M 514.53K -917.41K -1.88M -4.18M 3.25M -171.81K -10.06M -10.86M -13.48M -10.19M -277.9K -140.23K -30.66K n/a n/a n/a
Debt Repayment
-33.61K -33.61K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 250K 4.1M 4.5M 5.21M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-545.95K -472.2K -623.8K -1.06M -720.66K -720.66K -569.07K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
453.24K 366.65K 475.1K 1.04M 698.28K 1.12M 980.77K 411.7K 411.7K n/a n/a n/a n/a n/a n/a -387.81K -387.81K -387.81K
Financial Cash Flow
1.85M 953.56K 7.38M 7.59M 9.44M 9.87M 2.35M 2.27M 411.7K n/a n/a 21.07M 21.07M 21.07M 21.32M 3.71M 4.11M 4.83M
Net Cash Flow
-697K 71.71K -336.49K -947.42K 468.6K -679.39K -792.2K -4.14M -16.15M -17.49M -19.35M 5.44M 16.17M 16.82M 17.96M 953.72K 1.46M 2.5M
Free Cash Flow
-9.59M -8.8M -8.34M -7.82M -7.25M -6.51M -6.6M -6.55M -6.79M -7.02M -6.31M -5.7M -4.9M -4.25M -3.36M -2.76M -2.65M -2.33M